David Lawrence, Chief, Business Operations & PAO at ACORDA THERAPEUTICS INC (ACOR), sold 8,832 shares at $20.74 ($183K) on 2016-12-01, disclosed to the SEC on 2016-12-05.
Seasonal sale ($183k) by Chief, Business Operations & PAO — this insider has traded ACOR in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.74 | 4,416 | $92K | 50.0% |
| 2 | $20.74 | 4,416 | $92K | 50.0% |
| Total | $20.74 avg | 8,832 | $183K | 100% |
| Filing → |
| ACOR | SELL | 2018-12-06 | $102K | — | Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-06-11 | $1.3M | — | Filing → |